STAAR Surgical Shares Outstanding 2010-2023 | STAA

STAAR Surgical shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
STAAR Surgical Annual Shares Outstanding
(Millions of Shares)
2023 49
2022 49
2021 49
2020 48
2019 47
2018 45
2017 41
2016 40
2015 39
2014 38
2013 39
2012 36
2011 37
2010 35
2009 32
STAAR Surgical Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 49
2023-09-30 49
2023-06-30 50
2023-03-31 50
2022-12-31 49
2022-09-30 50
2022-06-30 49
2022-03-31 49
2021-12-31 49
2021-09-30 50
2021-06-30 49
2021-03-31 49
2020-12-31 48
2020-09-30 48
2020-06-30 45
2020-03-31 45
2019-12-31 47
2019-09-30 47
2019-06-30 47
2019-03-31 47
2018-12-31 45
2018-09-30 46
2018-06-30 44
2018-03-31 43
2017-12-31 41
2017-09-30 42
2017-06-30 41
2017-03-31 41
2016-12-31 40
2016-09-30 40
2016-06-30 40
2016-03-31 40
2015-12-31 39
2015-09-30 40
2015-06-30 39
2015-03-31 38
2014-12-31 38
2014-09-30 38
2014-06-30 38
2014-03-31 38
2013-12-31 39
2013-09-30 39
2013-06-30 38
2013-03-31 37
2012-12-31 36
2012-09-30 36
2012-06-30 36
2012-03-31 38
2011-12-31 37
2011-09-30 37
2011-06-30 36
2011-03-31 36
2010-12-31 35
2010-09-30 35
2010-06-30 35
2010-03-31 35
2009-12-31 32
2009-09-30 35
2009-06-30 31
2009-03-31 30
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.081B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
West Pharmaceutical Services (WST) United States $26.529B 47.54
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Merit Medical Systems (MMSI) United States $4.697B 25.74
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00